Pacira Pharmaceuticals buy melinda
Start price
22.03.17
/
50%
€42.17
Target price
26.04.17
€80.28
Performance (%)
0.53%
End price
26.04.17
€42.39
Summary
This prediction ended on 26.04.17 with a price of €42.39. The BUY prediction by melinda for Pacira Pharmaceuticals closed nearly unchanged. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Pacira Pharmaceuticals | -9.722% | -9.722% | -4.412% | -42.647% |
| iShares Core DAX® | 1.644% | 4.865% | 25.089% | 64.694% |
| iShares Nasdaq 100 | 0.747% | 2.923% | 8.975% | 109.729% |
| iShares Nikkei 225® | 2.442% | 6.212% | 21.408% | 55.832% |
| iShares S&P 500 | 0.618% | 2.843% | 5.726% | 67.674% |
Comments by melinda for this prediction
In the thread Pacira Pharmaceuticals diskutieren
$ PCRX bekräftigt mit einem Outperform bei Wedbush. $ 89 PT
A +
Stopped prediction by melinda for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€35.51
29.01.19
29.01.19
€42.39
02.05.19
02.05.19
19.77%
02.05.19
02.05.19
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€36.31
27.08.16
27.08.16
€40.59
27.02.17
27.02.17
7.95%
27.02.17
27.02.17
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€36.95
19.10.15
19.10.15
€63.14
15.12.15
15.12.15
78.88%
15.12.15
15.12.15